New stroke drug begins human testing

NCT ID NCT06447415

Summary

This early-stage study tested the safety and initial effectiveness of a new injection called HRS-7450 for people who recently had an ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The trial involved 64 participants who received the drug within 24 hours of their stroke symptoms starting. Researchers primarily monitored for serious side effects like brain bleeding while also checking if the treatment helped improve stroke symptoms.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • The First Affiliated Hospital of Sun Yat sen University

    Guangzhou, Guangdong, 510062, China

Conditions

Explore the condition pages connected to this study.